Literature DB >> 3211149

p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line.

S Giordano1, M F Di Renzo, R Ferracini, L Chiadò-Piat, P M Comoglio.   

Abstract

A protein with an Mr of 145,000 (p145) was detected by antibodies to phosphotyrosine by Western blot (immunoblot) analysis. This protein was phosphorylated on tyrosine in a gastric carcinoma cell line. In cells that were metabolically labeled with 32Pi, this protein was phosphorylated on tyrosine and serine. p145 is a cysteine-rich transmembrane glycoprotein. The extracellular domain could be labeled by 125I under nonpermeating conditions and was cleaved by mild trypsin treatment of intact cells. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis under nonreducing conditions revealed a shift of p145 mobility to an apparent Mr of 190,000. After immunoprecipitation with phosphotyrosine antibodies, p145 displayed a strong associated protein kinase activity in vitro, becoming phosphorylated on tyrosine. There was no immunological cross-reaction between p145 and known tyrosine kinases. Both in vivo and in vitro tyrosine phosphorylations were unaffected by the addition of known growth factors. However, p145 was rapidly dephosphorylated in vivo when cells were exposed to low pH, a condition that is known to dissociate ligands from their receptors. These data suggest that p145 is associated with a protein tyrosine kinase activity which, in the tumor cell line studied, is activated by an as yet unidentified factor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3211149      PMCID: PMC363588          DOI: 10.1128/mcb.8.8.3510-3517.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

Review 1.  A thousand and one protein kinases.

Authors:  T Hunter
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

Review 2.  Signal transduction in human T lymphocytes.

Authors:  D C Linch; D L Wallace; K O'Flynn
Journal:  Immunol Rev       Date:  1987-02       Impact factor: 12.988

3.  Kinetics and regulation of the tyrosine phosphorylation of epidermal growth factor receptor in intact A431 cells.

Authors:  E Sturani; R Zippel; L Toschi; L Morello; P M Comoglio; L Alberghina
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

4.  Molecular characterization of the human trk oncogene.

Authors:  D Martin-Zanca; G Mitra; L K Long; M Barbacid
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

5.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors.

Authors:  M Park; M Dean; K Kaul; M J Braun; M A Gonda; G Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes.

Authors:  C W Rettenmier; M F Roussel; R A Ashmun; P Ralph; K Price; C J Sherr
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

9.  Activation of the protein-tyrosine kinase associated with the bombesin receptor complex in small cell lung carcinomas.

Authors:  G Gaudino; D Cirillo; L Naldini; P Rossino; P M Comoglio
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

10.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  26 in total

1.  The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation.

Authors:  L Naldini; E Vigna; R Ferracini; P Longati; L Gandino; M Prat; P M Comoglio
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).

Authors:  A Mondino; S Giordano; P M Comoglio
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

3.  C-terminal truncated forms of Met, the hepatocyte growth factor receptor.

Authors:  M Prat; T Crepaldi; L Gandino; S Giordano; P Longati; P Comoglio
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

4.  An 'in-cell trial' to assess the efficacy of a monovalent anti-MET antibody as monotherapy and in association with standard cytotoxics.

Authors:  Silvia Benvenuti; Alessandra Gentile; Luca Lazzari; Addolorata Arnesano; Livio Trusolino; Paolo M Comoglio
Journal:  Mol Oncol       Date:  2013-12-18       Impact factor: 6.603

5.  Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody.

Authors:  Simona Cignetto; Chiara Modica; Cristina Chiriaco; Lara Fontani; Paola Milla; Paolo Michieli; Paolo M Comoglio; Elisa Vigna
Journal:  Mol Oncol       Date:  2016-03-28       Impact factor: 6.603

6.  Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence.

Authors:  Valentina Martin; Simona Corso; Paolo M Comoglio; Silvia Giordano
Journal:  Mol Oncol       Date:  2014-06-24       Impact factor: 6.603

7.  Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene.

Authors:  S Giordano; Z Zhen; E Medico; G Gaudino; F Galimi; P M Comoglio
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

8.  Protein tyrosine kinases in human breast cancer: kinetic properties and evidence for the presence of two forms of native enzyme.

Authors:  Y Durocher; S Chevalier
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

9.  Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition.

Authors:  Simona Corso; Elena Ghiso; Virna Cepero; J Rafael Sierra; Cristina Migliore; Andrea Bertotti; Livio Trusolino; Paolo M Comoglio; Silvia Giordano
Journal:  Mol Cancer       Date:  2010-05-26       Impact factor: 27.401

10.  Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.

Authors:  S Rong; M Bodescot; D Blair; J Dunn; T Nakamura; K Mizuno; M Park; A Chan; S Aaronson; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.